The Skin Cancer Foundation, the leading nonprofit organization for public and professional skin cancer education, has launched Carcinomas & Keratoses. This new digital publication sheds light on the most recent and important developments in keratinocyte cancers and pre-cancers, including basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), and actinic keratosis (AK). Featuring content written by expert dermatologists and The Skin Cancer Foundation’s editorial team, coverage includes new strategies for early detection and diagnosis to breakthrough treatments for advanced basal cell carcinoma and cutaneous squamous cell carcinoma.
“I see this publication as a golden opportunity to help a broad range of professionals provide the best care possible to patients who have or are at risk for skin cancer,” says Désirée Ratner, MD, editor-in-chief of Carcinomas & Keratoses and a clinical professor of dermatology at NYU Langone Health. “We want to provide current, relevant, accessible information to medical professionals on key issues related to the keratinocyte cancers and precancers, from epidemiology, pathogenesis, and prevention to detection, diagnosis, and treatment.”
The publication will live on its own platform,, where professionals are encouraged to sign up to regularly receive new issues. In the inaugural issue, Mark Teich, The Skin Cancer Foundation’s scientific director, and Kishwer Nehal, MD, discuss what keratinocyte carcinomas are and why they deserve to be taken more seriously. According to the latest figures, in 2019, more than twice as many people (over 15,000) will die from cutaneous squamous cell carcinoma in the United States than from melanoma (7,230). Nonmelanoma skin cancers make up the vast majority of skin cancer incidence but seem to receive the least attention. At last count, compared with 96,480 cases of invasive melanoma each year in the United States, there are over 5.4 million cases of basal cell carcinoma and cutaneous squamous cell carcinoma each year, occurring in more than 3.3 million people.
“We recognized a gap in knowledge that needed to be filled,” says Deborah S. Sarnoff, MD, president of The Skin Cancer Foundation. “For many years, our Melanoma Letter has offered physicians the latest research and treatment techniques for melanoma. With C&K, we’re drastically expanding the topics we can cover. Our goal is to present this information in a way that appeals not only to dermatologists, physician assistants, and nurse practitioners who treat skin cancer, but also to internists and specialty practitioners who are often on the periphery of skin cancer detection and treatment. This is also a wonderful resource for medical students and dermatology residents.”


North Dakota became the latest state to untangle natural hair braiders and eyebrow threaders from a thicket of licensing red tape thanks to a bill signed earlier this year. Before the law was signed, threaders could only work in North Dakota if they became a licensed aesthetician, a credential that requires a minimum of 600 hours of coursework. The requirements for braiders were even more burdensome, requiring a cosmetology license, which needs at least 1,800 hours of classes or 420 days.
Under HB 1345, braiders and threaders are completely exempt from licensing and are now free to work without a government permission slip. With the governor’s signature, North Dakota is now the 26th state to end licensing for hair braiders. Among those states, 15 (including South Dakota) enacted their reforms in just the past five years. Bills to repeal licenses for braiders are currently pending in Florida, Minnesota, Pennsylvania, and Rhode Island.


In Sooke, British Columbia, Seaflora’s new skin brightening formula is the result of four years of development working with the National Research Council of Canada. Seabright Moisturizing Brightener has a potent combination of unique, kelp bioactives to decrease melanin and target hyperpigmentation. These potent marine bioactives create the most powerful skin brightening solution to date. Seaflora has strategically combined the unique skin brightening capability of their kelp complex with effective natural brightening ingredients to work on different cellular mechanisms that cause hyperpigmentation. The Seabright kelp complex is scientifically shown to be faster and more effective at inhibiting the key enzyme, tyrosinase, at lower concentrations than arbutin and kojic acid. It works in two ways, directly inhibiting tyrosinase and toning down melanocyte activity.
Oxy-Resveratrol exhibits greater inhibitory effect on the tyrosinase enzyme than ordinary resveratrol, kojic acid, and arbutin. In vivo study carried out on 16 volunteers for four weeks of treatments recorded: 71 percent reduction in melanin, 28 percent reduction in dark spots, and 25 percent reduction in yellow pigment.


Weleda, the European personal care and beauty brand, has partnered with international recycling leader TerraCycle to offer consumers an easy way to recycle packaging waste from their entire Skin Food line of products.
“Preserving the balance between what we take from nature with what we give back is our core value,” says Rob Keen, CEO of Weleda North America. “This respect for nature is in our DNA and it guides everything we do – from our innovative biodynamic farming practices that actually pull carbon out of the atmosphere to our manufacturing facilities in France, Germany, and Switzerland that use energy from 100% renewable sources. We also employ thoughtful ingredient sourcing and ethical partnerships that protect the life, energy, and potency of our products. Now, we are teaming up with TerraCycle to ensure that our recently launched Skin Food packaging has every opportunity to be recycled.”
Through the Weleda Recycling Program, consumers can now send in their empty packaging from the entire Skin Food line of products to be recycled for free. Participation is easy and requires users to sign up on the TerraCycle program page and mail in the packaging waste using a prepaid shipping label. Once collected, the packaging is cleaned and melted into hard plastic that can be remolded to make new recycled products. Additionally, collectors can earn one dollar per pound of waste sent to TerraCycle to donate to a non-profit, school, or charitable organization of their choice.
“We are pleased to be working with Weleda to offer consumers a free recycling program to complement their new Skin Food line of products,” said TerraCycle CEO and Founder, Tom Szaky. “By participating in the Weleda Recycling Program, consumers have a unique opportunity to demonstrate their respect for the environment by diverting their packaging waste from landfills, as well as through the products that they choose to include in their beauty regimen.”
Among Weleda’s many different sustainability efforts, packaging improvements are a continual focus area for the brand. In fact, through their efforts, four tons of material were saved in 2017 by optimizing the weight of the screw caps used for Weleda’s aluminum tubes. Weleda looks to increase the amount of recycled material used in its packaging, with some newer launches using up to 70% recycled plastic for packaging material.


AIM at Melanoma announces the grand opening of the first branch of the International Melanoma Tissue Bank Consortium (IMTBC) at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center. The Pittsburgh site is one of six global locations of the consortium. These six institutions and their researchers will collect a critical mass of fresh-frozen primary tumor tissue for collaborative research, with a goal of 500 samples collected in the next two years. A fresh-frozen primary tissue bank – fully annotated and collaborative – has never been achieved before in melanoma and it has taken more than a decade of dedicated work to accomplish. The IMTBC is a global first because of the following combination of factors:
• It is a consortium – the six institutions are sharing data and tissue samples with each other
• It is collaborative – tissue samples and data will be available for researchers around the world to apply to study
• The tissue will be fresh-frozen – RNA is preserved, unlike in the standard formalin fixed, paraffin embedded process
• The tumors are primary – not metastasized
• There will be a critical mass – a goal of 500 in the first two years and continued collection thereafter
• Full annotation will accompany each tissue – patient data, including full medical history (depersonalized) will be available for study along with the tissue
• Samples will accompany each tissue – blood and urine samples will be collected for each patient
“The primary tumor is the holy grail of resources for melanoma researchers,” says John M. Kirkwood, MD, usher professor of medicine, dermatology, and translational science and co-leader of the melanoma and skin cancer program at UPMC Hillman Cancer Center. “We know the information we seek about melanoma is available in primary tumors, but researchers need a critical mass of fresh-frozen tissue and all the relevant patient data to understand it. We believe fresh-frozen primary tissue can help us discover the answers we seek, such as: whose melanomas will spread and become deadly; who will respond to immunotherapies; and, ultimately, how we can cure this disease.”
UPMC Hillman Cancer Center is one of six branches of the IMTBC – four in the United States and two in Australia. The remaining locations have approved their contracts to become fully functioning branches of the IMTBC and are awaiting only final details before they, too, will open and accelerate the collection of tissue.
“Fifteen years ago, many researchers told me that a collaborative fresh-frozen primary tissue bank would propel research, but they also told me it would be impossible to accomplish,” says Val Guild, the founder and president of AIM at Melanoma, who lost her 26-year-old daughter, Charlie, to the disease in 2003. “And, there were times over the years that I felt like giving up. But, I’m extremely proud to announce this grand opening of the UPMC branch of the International Melanoma Tissue Bank Consortium today, on what would have been my daughter Charlie’s 42nd birthday. I believe the IMTBC will help us get to the place where no family suffers as we did.”


Repêchage CEO and Founder, Lydia Sarfati, is a contributing author to the new “Milady’s Standard Esthetics: Fundamentals, Twelfth Edition” available at the end of this month. The textbook was first published in 1978 and, today, is the most widely used aesthetics textbook in the world. Sarfati contributed three main chapters on the treatment room, performing core facial treatments, and facial massage technique, working closely with the Cengage editors to create new content, as well as expand on the existing curriculum. In addition, for this new edition, Sarfati wrote a memoriam for Milady founder, Dr. Joel Gerson.
“Proper education is essential for our field and I am honored to be a contributing author to the Milady’s Standard Esthetics: Fundamentals, Twelfth Edition,” said Sarfati. “Milady Esthetics is the landmark text founded by my dear friend and aesthetics mentor, the late Joel Gerson. I know it was his mission to elevate the standards for aesthetics and I am proud to continue his work in the industry.”
Sarfati is a prolific writer and author of “Success at Your Fingertips: How to Succeed in the Skin Care Business” and “The Repêchage Book of Skincare Science & Protocols.” Sarfati is also a contributing editor for aesthetics magazines, including DERMASCOPE Magazine.


Massage Envy, the leading provider of therapeutic massage and skin care services collectively across its franchise network, announced it has formed a partnership with professional skin care brand Obagi to provide exclusive facial services and sell Obagi Medical products at its nearly 1,200 franchised locations nationwide.
Customizable facials were uniquely designed to use Obagi’s medical-grade skin care products, which incorporate powerful ingredients such as retinol and vitamin C.
“We are delighted to partner with Obagi, a trusted, professional brand that is adored by consumers and aestheticians,” said Joe Magnacca, Massage Envy franchising president and CEO. “We are proud to offer products from the Obagi Medical line, which has been carried in physicians’ offices for more than 30 years. This is a huge differentiator for the Massage Envy brand and will enable us to serve consumers with the best products and treatment protocols.”
“Massage Envy has designed proprietary facial treatments specifically using Obagi Medical products that really deliver on what consumers want – an enjoyable treatment that provides great results,” said Christy Bower, Massage Envy vice president of products and services. “That’s exactly what they get with this highly personalized, spa-like experience.”
The facials include an initial consultation with an expert aesthetician to help understand the client’s particular skin concerns and determine what goals the client wants to achieve, and how those concerns may be addressed during the service. Each aesthetician undergoes protocol-specific training to effectively deliver this particular service, as well as an Obagi Medical certification process.


Bioelements is excited to announce a new social media and content coordinator, Izzy Gut.
Gut comes to the Bioelements team with intensive expertise in hands-on creative direction and content production for print and digital platforms, including social media, copywriting, photography, video, merchandising, and community events.
A Chicago native, Gut has a background in magazine journalism and gender studies, with years of multimedia communications experience in both the non-profit and start-up sectors. She brings a sharp visual eye and maintains a high standard in her work, along with a passion for innovation and cohesive aesthetics. Her emphasis will be on enhancing the brand voice on both B2B and B2C channels through authentic storytelling and cultivating new content strategy opportunities.
“I am so genuinely thrilled to be joining the Bioelements family and sharing my talents with such a respected brand,” says Gut. “I feel so welcomed and empowered to be my best self both personally and professionally. I look forward to all the incredible initiatives Bioelements has planned and working together to bring them to life.”


Indie Beauty Media Group (IBMG) will host the third annual Indie Beauty Expo (IBE) Dallas on Wednesday, May 15 and Thursday, May 16. The two-day exposition offers buyers, press, influencers, investors, and shoppers an opportunity to discover and transact with a vibrant collection of over 70 independent beauty brands from around the world.
“The attendee to exhibitor ratio has been very favorable at the Dallas shows,” said co-founder Nader Naeymi-Rad. “Our team has worked incredibly hard forging strong relationships with Texas-area buyers and consumers. Furthermore, hosting the BeautyX Retail Summit in Dallas, which takes place the two days prior to IBE Dallas, enables many national and international buyers to participate in both events.”
Beauty lovers are invited to attend SHOP INDIE (May 15) to discover and buy the best and newest independent beauty products and mingle with brand founders and owners. TRADE INDIE (May 16) is open only to trade, press, and industry professionals. IBE Dallas continues to deliver on the brand’s promise of showcasing the widest selection of commercially-ready, independent brands to buyers, press, and influencers.
“We have many local brands and global brands that exhibit in Dallas, providing an interesting mix, from proprietary technology to fascinating founder stories and unique ingredients,” adds IBE Co-Founder Jillian Wright. “There is something here to pique everyone’s interest.”
For the first time at IBE, a large-scale device used for body contouring procedures will be showcased on the floor. Erchonia’s Zerona Z6 Laser is the first device in the world to receive FDA clearance for non-invasive fat loss and body contouring.
“We recently received over-the-counter clearance on the Zerona Z6 Fat Loss Laser, so the timing was perfect to bring this amazing technology to the spa industry where it can be utilized without a medical director,” said Joseph Zapolsky III, national sales manager for Erchonia Corporation. “IBE is the best place to meet and establish connections with high level industry professionals who need this product.”
IBE Dallas 2019 will be IBE’s 13th show since its inception in 2014, solidifying IBE’s reputation as the premier destination to discover cutting-edge, independently owned beauty brands.